Evaxion raises about $775K net in stock offering

The completed sales increased nominal share capital by DKK 2,514,975, bringing Evaxion’s share capital to DKK 115,283,514.

Available on EDGAR 11/04/2026 - 06:30 AM EST Accepted by SEC EDGAR 11/04/2026 - 06:30 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Evaxion A/S sold 201,198 American Depositary Shares (ADSs) in an at-the-market (ATM) offering between October 19 and October 21, 2026, at an average price of $3.9714 per ADS. The sales were made under the Capital Demand™ Sales Agreement with Jones Trading Institutional Services LLC. After fees and expenses, Evaxion received approximately $775,068 in net proceeds.

Each ADS represents 50 ordinary shares. The sales increased nominal share capital by DKK 2,514,975, bringing total nominal share capital to DKK 115,283,514. Evaxion amended its Articles of Association on October 20, October 21 and October 22, 2026, to reflect the capital increases.

Filing Explained

This report is incorporated by reference into Evaxion’s listed Form S-8, F-3 and F-1 registration statements from its filing date, making its disclosures part of those statements unless later filed or furnished documents supersede them.

Key Figures

ADSs sold: 201,198 ADSs Average price: $3.9714 per ADS Net proceeds: Approximately $775,068 +3 more

6 metrics

ADSs sold 201,198 ADSs At-the-market sales between October 19 and October 21, 2026

Average price $3.9714 per ADS At-the-market sales between October 19 and October 21, 2026

Net proceeds Approximately $775,068 After deducting fees and expenses from the ADS sales

Ordinary shares per ADS 50 ordinary shares Each ADS represents this number of ordinary shares

Nominal share capital increase DKK 2,514,975 Aggregate increase associated with the ADS sales

Nominal share capital DKK 115,283,514 Aggregate share capital after the increases

Key Terms

American Depositary Shares, at-the-market (ATM) offering, Capital Demand™ Sales Agreement, nominal value

4 terms

American Depositary Shares financial

"aggregate of 201,198 American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

at-the-market (ATM) offering financial

"sold in an at-the-market (ATM) offering"

An at-the-market (ATM) offering is a way for a publicly traded company to sell new shares directly into the open market over time at the current trading price, usually through a broker, rather than in one big sale. For investors it matters because it can provide flexible funding without a large one-time price shock, but it also increases the number of shares outstanding and can gradually reduce each shareholder’s ownership and potentially put downward pressure on the stock price—think of a shop quietly adding more of the same product onto the shelves at the going price.

Capital Demand™ Sales Agreement financial

"terms contained in that certain Capital Demand™ Sales Agreement"

nominal value financial

"ordinary shares, DKK 0.25 nominal value"

Nominal value is the stated or face amount assigned to a financial instrument — for shares it’s the par value printed on the stock certificate, and for money or returns it can mean the number not adjusted for inflation. Think of it like a price tag on an item versus its buying power: the tag tells you the label, but not how much you can actually buy. Investors care because nominal values affect accounting, legal capital, dividend calculations and comparisons over time when inflation may distort real worth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EVAX ADSs did Evaxion sell, and at what average price?

Evaxion sold 201,198 ADSs at an average price of $3.9714 per ADS between October 19 and October 21, 2026, in an at-the-market offering.

How much net proceeds did EVAX receive from the ADS sales?

Evaxion received approximately $775,068 in net proceeds after deducting fees and expenses from the ADS sales.

How many ordinary shares does one EVAX ADS represent?

Each ADS represents 50 ordinary shares of Evaxion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2026

Commission File Number: 001-39950

Evaxion A/S

(Exact Name of Registrant as Specified in Its Charter) 

Dr. Neergaards Vej 5f

DK-2970 Hoersholm

Denmark

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒            Form 40-F ☐

INCORPORATION BY REFERENCE

This report on Form 6-K shall be deemed to be incorporated by reference in Evaxion A/S’s (the “Company”) registration statements on Form S-8 (File No. 333-255064), on Form F-3 (File No. 333-265132), on Form F-1, as amended (File No. 333-266050), Form F-1 (File No. 333-276505), Form F-1 (File No. 333-279153), Form F-1 (File No. 333-283304), and Form F-3 (File No. 333- 285778), including any prospectuses forming a part of such registration statements and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Amendment to Articles of Association

During the period between October 19, 2026 and October 21, 2026, the Company sold an aggregate of 201,198 American Depositary Shares (the “ADSs”), representing the Company’s ordinary shares, DKK 0.25 nominal value with each ADS representing fifty (50) ordinary shares, at an average price of USD $3.9714 per ADS, consisting of (i) 15,699 ADSs sold on October 19, 2026 at an average price of USD $3.1533 per ADS, (ii) 170,426 ADSs sold on October 20, 2026 at an average price of USD $4.0069 per ADS, and (iii) 15,073 ADSs sold on October 21, 2026 at an average price of USD $4.4222 per ADS. The ADSs were sold in an at-the-market (ATM) offering pursuant to the terms and subject to the conditions contained in that certain Capital Demand™ Sales Agreement between the Company and Jones Trading Institutional Services LLC dated October 3, 2022. After deducting fees and expenses, net proceeds to the Company from the sales of the ADSs were approximately $775,068.

In connection with such sales, the Company registered share capital increases with the Danish Business Authority as follows: (i) nominal DKK 196,237.50, corresponding to the 784,950 ordinary shares represented by the 15,699 ADSs sold on October 19, 2026, with effect date of October 20, 2026; (ii) nominal DKK 2,130,325, corresponding to the 8,521,300 ordinary shares represented by the 170,426 ADSs sold on October 20, 2026, with effect date of October 21, 2026; and (iii) nominal DKK 188,412.50, corresponding to the 753,650 ordinary shares represented by the 15,073 ADSs sold on October 21, 2026, with effect date of October 22, 2026. Such registrations represent aggregate share capital increases of nominal DKK 2,514,975, corresponding to an aggregate increase in the Company’s share capital to nominal DKK 115,283,514 through the issuance of such 201,198 ADSs representing the Company’s ordinary shares.

The Company’s Articles of Association were amended on October 20, 2026, October 21, 2026 and October 22, 2026, respectively, to reflect these capital increases and are attached hereto as Exhibit 1.1.

Exhibits

Exhibit
No.		Description
1.1		Articles of Association

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Evaxion A/S
Date: November 4, 2026	By:	/s/  Dr. Helen Tayton-Martin
		Dr. Helen Tayton-Martin
		Chief Executive Officer

Filing Exhibits & Attachments

1 document

Other Documents

• EX-1.1 EXHIBIT 1.1 1.9 MB